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Abstract 
It is clear that scientists are now only beginning to comprehend the complexity of transdermal drug delivery. 
Elucidation of the biochemical composition and functioning of the intrinsic diffusional barrier of the stratum 
corneum has prompted investigation of chemical and physical means of enhancing the percutaneous penetration of 
poorly absorbed drugs. Chemical enhancers that aid absorption of co-administered moieties are currently believed 
to improve solubility within the stratum corneum or increase lipid fluidity of the intracellular bilayers. Alternatively, 
the use of ionto- or phonophoresis may facilitate the absorption of some drug molecules by physical alteration of 
the barrier. The role of penetration enhancer inclusion in topical formulations has been well documented and will 
undoubtedly, in the future, permit the delivery of broader classes of drugs through the stratum corneum. 
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1. Introduction 
An approach commonly researched for pro- 
moting permeation through the skin of poorly 
penetrating drug molecules is the formulation of 
a suitable delivery vehicle. or incorporation of a 
chemical enhancer into transdermal delivery sys- 
tems. Alternatively. physical mechanisms uch as 
iontophoresis and phonophoresis can be used for 
promoting the diffusion of certain classes of 
drug. The primary role of the stratum corneum is 
to provide a substantial diffusional barrier and 
thereby protect the body from ingress by xeno- 
biotics. Concepts pertaining to the way scientists 
view the stratum corneum have changed marked- 
ly: the idea that the stratum corneum is a “layer 
of dead cells” is outdated. The dermal barrier of 
the body is now known to be a complex. dy- 
namic, biochemical environment that responds to 
ambient conditions to maximise the protective 
barrier. Diffusional resistance is known to reside 
in the stratum corneum and is constituted by a 
complex interaction of, especially, lipid and 
proteinaceous components which creates fairly 
distinct hydrophilic and lipophilic penetration 
pathways. The increase in the understanding 01 
the make-up and function of the stratum cor- 
neum in recent years has resulted in a diverse 
range of compounds being tested for their ability 
to facilitate improved permeation of the skin 
portal by co-administered drugs. The biochemi- 
cal order of the intercellular lipid matrices of the 
stratum corneum [l] or the keratinized environ- 
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Fig. 1. SchematIc representation of the facilitated drug 
diffusion channels formed by chemical cnhanccr disruption of 
ordered intercellular lipid hilayers. 
ment of the corneocytes must be altered to allow 
the penetration of compounds at a suitable rate 
to the desired site of activity (Fig. 1). Ideal 
penetration enhancers should specifically pro- 
mote the penetration of compounds across the 
skin barrier without exhibiting irreversible ef- 
fects on its properties [2]. 
2. Goals of transdermal delivery using 
penetration enhancers 
The ultimate goal of transdermal drug delivery 
is to ensure that compounds are delivered, pre- 
ferably at a specific rate, to the systemic circula- 
tion. Penetration of drug to the dermal vascula- 
ture follows exposure of the skin to a dosage 
form from which the active must partition, fol- 
lowed by diffusion of the compound through the 
external strata to the dermis. 
Partitioning of drug from the dosage form is 
highly dependent on the relative solubility of the 
drug in the components of the delivery system 
and in the stratum corneum. Thus, the formula- 
tion of the vehicle may markedly influence the 
degree of penetration of the drug [3]. Partition- 
ing is governed to a large extent by the thermo- 
dynamic activity of the drug in the vehicle and 
this aspect is, therefore, of major importance in 
controlling the degree of penetration of any one 
compound [4]. 
Since diffusion of drugs across the skin is a 
passive process. compounds with low solubility 
and affinity for the hydrophilic and lipophilic 
components of the stratum corneum would, 
theoretically. partition at a slow rate. These 
difficulties may be overcome by addition of a 
chemical adjunct to the delivery system that 
would promote drug partitioning into the stratum 
corneum. Furthermore, penetration enhancer 
chemicals added to topical vehicles usually also 
partition into the stratum corneum and affect the 
intrinsic diffusional barrier properties of this 
structure. Other factors that require considera- 
tion when penetration enhancers are included 
into formulations are the effects that these 
chemicals may have on the solubility of the drug 
in the delivery vehicle (influencing the diffusion- 
al gradient) or the possible effects that the 
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chemical may have on the state of hydration of 
the diffusional barrier. 
3. Chemical enhancers 
The environs of the stratum corneum are 
thought to be the site of activity of the chemical 
penetration enhancers. Whilst the mechanisms by 
which these compounds are thought to promote 
permeation are now only beginning to be eluci- 
dated, their activity is thought to be a result of 
multiple effects within the diverse biochemical 
environments of this layer. We currently believe 
that most chemical enhancers are active by 
spatial disruption of the normally ordered ar- 
rangement of the intercellular molecules. It is the 
uniform, ordered nature of these biochemicals, 
especially lipid bilayers, that maintain and pro- 
mote the diffusional resistance of the barrier. In 
addition, modification of the intracellular en- 
vironment of the corneocyte may also be influen- 
tial in the penetration of certain classes of drug. 
The range of the biochemical components 
found in the barrier layers suggests that penetra- 
tion enhancer chemicals from diverse family 
groups should be effective in promoting percuta- 
neous penetration. The range of chemical en- 
hancers that have been researched to date is vast; 
a review of the most promising enhancers from 
the different classes has already been presented 
[5]. An overview of some of the compounds and 
their proposed mechanisms of action is presented 
here. 
3.1. Sulfoxides 
Dimethylsulfoxide (DMSO) is an effective 
penetration enhancer that promotes permeation 
by reducing skin resistance to drug molecules or 
by promotion of drug partitioning from the 
dosage form [6]. It has been postulated that 
DMSO denatures the intercellular structural pro- 
teins of the stratum corneum [7], or promotes 
lipid fluidity by disruption of the ordered struc- 
ture of the lipid chains [S]. In addition, DMSO 
may alter the physical structure of the skin by 
elution of lipid, lipoprotein and nucleoprotein 
structures of the stratum corneum [9]. De- 
cylmethylsulfoxide (DCMS) is thought to pro- 
mote permeation enhancement as a result of 
protein-DCMS interaction creating aqueous 
channels, in addition to lipid interactions [lo]. 
3.2. Alcohols 
Alcohols may influence transdermal penetra- 
tion by a number of mechanisms. The alkyl chain 
length of the alkanols is an important parameter 
in the promotion of permeation enhancement. 
Augmentation appears to increase as the number 
of carbon units increases, up to a limiting value 
[ll]. In addition, lower molecular weight al- 
kanols are thought to act as solvents, enhancing 
the solubility of drugs in the matrix of the 
stratum corneum [ll]. Disruption of the stratum 
corneum integrity through extraction of bio- 
chemicals by the more hydrophobic alcohols 
almost certainly also contributes to enhanced 
mass transfer through this tissue [12]. 
3.3. Polyols 
The molecular complexity of different glycol 
molecules is a determinant of their efficacy as 
permeation enhancers. Solubility of the drug in 
the delivery vehicle is markedly influenced by the 
number of ethylene oxide functional groups on 
the enhancer molecule; this solubility modifica- 
tion may either enhance or retard transdermal 
flux depending on the specific drug and delivery 
environment [13]. The activity of propylene 
glycol is thought to result from solvation of (Y- 
keratin within the stratum corneum; the occupa- 
tion of proteinaceous hydrogen bonding sites 
reducing drug-tissue binding and thus promoting 
permeation [6]. 
3.4, Alkanes 
Long chain alkanes (C-C,,) have been 
shown to enhance skin permeability by non-de- 
structive alteration of the stratum corneum bar- 
rier [14]. These findings were confirmed in 
studies in which nonane was investigated as an 
enhancer [15], although there must be some 
destructive solubilization and biochemical extrac- 
tion caused by these lipophilic solvents. 
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3.5. Fatty acids 
Selective perturbation of the intercellular lipid 
bilayers in the stratum corneum appears to be 
the major mode of enhancing activity of the fatty 
acids [16]. Structure-activity relationships are 
predominant: variation of octadecanoic acids 
with respect to the number of double bonds and 
cisltrans configuration of the isomers, for exam- 
ple, show differences in their penetration en- 
hancing effects [17]. More specifically, oleic acid 
has been found to decrease the phase transition 
temperatures of the skin lipids with a resultant 
increase in motional freedom or fluidity of these 
structures [16]. 
3.6. Esters 
Esters such as ethyl acetate are relatively 
polar, hydrogen bonding compounds that may 
enhance permeation in a similar manner to the 
sulphoxides and formamides by penetrating into 
the stratum corneum and increasing the lipid 
fluidity by disruption of lipid packing [1X]. A 
similar mode of action is proposed for isopropyl 
myristate and, in addition. the aliphatic esters 
may influence partitioning between vehicle and 
skin by solubilization effects 1191. 
.?.7. Amines and amides 
3.7.1. Urea 
Urea promotes transdermal permeation by 
facilitating hydration of the stratum corneum and 
by the formation of hydrophilic diffusion chan- 
nels within the barrier [20]. Cyclical urea per- 
meation enhancers are biodegradable and non- 
toxic molecules consisting of a polar parent 
moiety and a long chain alkyl ester group. As a 
result, penetration enhancement may be a conse- 
quence of both hydrophilic activity and lipid 
disruption mechanisms [21]. 
3.7.2. Dimethylacetamide and 
dimethylformamide 
These compounds are less potent penetration 
enhancing chemical alternatives to DMSO. At 
low concentrations their activity as enhancers is a 
result of partitioning into the keratin regions. At 
higher concentrations they increase lipid fluidity 
by disruption of lipid packing as a result of 
solvation shell formation around the polar head 
groups of the lipids [22]. 
37.3. Pyrmlidones 
Pyrrolidone and its derivatives are reported to 
interact with both keratin [23] and with lipids 
(241 in the skin. Azone is known to show signifi- 
cant accelerant effects at low concentrations for 
both hydrophilic and hydrophobic drugs [25] and 
is one of the few enhancers that have been 
developed commercially. Differential scanning 
calorimetric studies have shown that azone af- 
fects lipid structures of the stratum corneum [6]. 
In addition, azone is reported to decrease transi- 
tion temperatures within lipid bilayers to induce 
formation of a liquid phase with a resultant 
increase in lipid fluidity [26]. 
3.8. Terpenes 
Both the mono- and sesquiterpenes are known 
to increase percutaneous absorption of com- 
pounds by increasing diffusivity of the drug in 
stratum corneum [27] and/or by disruption of the 
intercellular lipid barrier [28]. A further mecha- 
nism of activity that has been postulated is that 
the terpenoids increase electrical conductivity of 
tissues thereby opening polar pathways within 
the stratum corneum [29]. 
-7.5). Swface active agents 
Surface active agents function primarily by 
adsorption at interfaces and thus interact with 
biological membranes contributing to the overall 
penetration enhancement of compounds. Cat- 
ionic surfactants are more destructive to skin 
tissues causing a greater increase in flux than 
anionic surfactants [30]. The latter, in turn, 
produce greater increases in flux than nonionic 
surfactants [25]. Anionic surfactants may func- 
tion by alteration of the barrier function of the 
stratum corneum as a result of removal of water 
soluble agents that act as plasticizers [31]. Sodi- 
um lauryl sulphate has been implicated in revers- 
ible lipid modification with resultant disorganiza- 
tion of the stratum corneum and enhanced per- 
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meation [32]. In addition, nonionic surfactants 
are purported to be able to emulsify sebum, 
consequently altering partitioning potential of 
drugs in favour of enhanced permeation [33]. 
The permeation enhancement generated by 
these compounds may be dependent on the 
ability of drug to partition between the free and 
bound or micellar form of the enhancer. 
3.10. Cyclodextrins 
Cyclodextrins are biocompatible substances 
that can form inclusion complexes with lipophilic 
drugs with a resultant increase in their solubility, 
particularly in aqueous solutions [34]. However, 
cyclodextrins alone were determined be to less 
effective as penetration enhancers than when 
combined with fatty acids and propylene glycol 
]351. 
3.11. General 
Chemical penetration enhancers may subtly 
alter the solvent potential of the stratum cor- 
neum, possibly providing an area of greater 
affinity for the permeant thus ensuring a greater 
potential for partitioning of the drug into the 
skin. Additionally, the enhanced solubility of the 
permeant in the enhancer-modified stratum cor- 
neum, could facilitate the translocation of drug. 
Many penetration enhancers operate by disrup- 
tion of the intercellular lipid matrix of the 
stratum corneum, by either increasing fluidity of 
the medium thereby facilitating diffusion of the 
drug [16] or by formation of alternate domains 
within the bilayer structure [36]. These mecha- 
nisms may be operative simultaneously and, thus, 
may increase transdermal flux of a permeant to a 
greater degree than if each mechanism were 
operating alone [37]. 
4. Physical enhancers 
The enhancement of permeation of all drug 
molecules may not be accomplished effectively 
with chemicals; specific physical techniques of 
enhancement may provide an effective alterna- 
tive method for improved permeation in such 
cases. 
Iontophoresis, a technique which requires ap- 
plication of a small electrical current across the 
skin, has been used to deliver ionized drug 
molecules and peptides at a faster rate than 
normal [38,39]. Essentially, the charged molecule 
is forced into the stratum corneum as it is 
repelled from the electrode of similar polarity. A 
particular advantage of iontophoretic delivery is 
that the flux of the permeant can be effectively 
controlled by alteration of the applied current, 
thus tailoring therapy for specific conditions. The 
alteration of skin permeability following ion- 
tophoretic delivery is maintained for a brief 
period after termination of current application, 
after which normal barrier function is restored. 
This would suggest that physical changes of the 
skin or stratum corneum rather than electrostatic 
forces alone are responsible for improved penet- 
rability of the skin barrier. 
An alternative to iontophoresis is the applica- 
tion of ultrasound, or the use of phonophoresis, 
to enhance permeability of the skin to drug 
molecules [40,41]. The exact mechanism by 
which phonophoresis is thought to decrease the 
barrier potential is unknown, but may be a result 
of increased fluidity of the barrier domains and 
kinetic energy of the permeant molecules as a 
result of the conversion of wave energy to 
mechanical energy, and heat generation within 
the stratum corneum. The use of phonophoresis 
may be damaging to the skin structures if the 
frequency and intensity of application are exten- 
sive. 
5. Conclusions 
The entire field of transdermal drug delivery, 
and especially penetration enhancement, is still 
in its infancy. It is evident that for the transder- 
ma1 route to be effective for systemic drug 
delivery, particularly if the permeant of interest 
is poorly absorbed via the skin portal, a penetra- 
tion enhancer of some form is necessary. The 
role of the penetration enhancer is to reversibly 
alter the barrier properties of the skin by im- 
proved fluidity of the membrane structures or by 
facilitation of drug solubility within the skin. 
Alternatively, physical delivery to the vascula- 
ture using one of several methods. such as 
electrostatic repulsion or ultrasonic waves, may 
be used to promote drug penetration. The recent 
advances in modern analytical techniques, when 
applied to investigations of drug delivery through 
the skin [5], are facilitating elucidation of the 
mechanisms of action of enhancer chemicals and 
physical techniques. It is apparent that if diverse 
classes of drug are to be delivered via the 
transdermal route then most will require substan- 
tial enhancer augmentation because of generally 
poor intrinsic diffusivity. The essential role that 
enhancer excipients will play in topical formula- 
tions has, therefore, been established for the 
foreseeable future. 
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